BPC-157 + TB-500
A precision blend of two of the most studied repair-focused research peptides, prepared for protocols investigating combined activity.
$99.00 USD / vial
Vial size
Research use only. This material is supplied exclusively for lawful in-vitro laboratory research, analytical testing, and scientific study by qualified professionals. Not for human or veterinary use of any kind.
About BPC-157 + TB-500
This blend combines BPC-157 with TB-500, a synthetic fragment based on the actin-binding region of thymosin beta-4. The two compounds are frequently studied together in preclinical repair models because they are thought to act through complementary mechanisms, BPC-157 in relation to angiogenic signaling, TB-500 in relation to actin regulation and cell migration.
Supplying both compounds in a single lyophilized vial simplifies co-administration protocols and reduces handling variables. Lot documentation covers both constituents.
Documented research areas
- Combined-mechanism tissue repair studies
- Cell migration and actin regulation research
- Angiogenesis co-signaling models
- Formulation and co-stability studies
Technical profile
| Constituents | BPC-157 + TB-500 (1:1 blend) |
|---|---|
| TB-500 CAS | 885340-08-9 |
| BPC-157 CAS | 137525-51-0 |
| Form | Lyophilized powder |
| Purity | ≥ 99% each constituent (HPLC) |
| Storage | −20 °C, protect from light |
Testing & documentation
Every production lot of BPC-157 + TB-500 is analyzed by an independent third-party laboratory before release. Identity is confirmed by mass spectrometry and purity is quantified by high-performance liquid chromatography (HPLC), with a minimum release threshold of 99%.
A lot-specific Certificate of Analysis is available on request, email support@elevatebiolabs.co. Vials are filled and sealed under laboratory-standard conditions and shipped in tamper-evident packaging.